Apollo Hospitals Inks ₹1,650 Crore Deal to Acquire 450-Bed Super-Specialty Hospital in Bengaluru
Apollo Hospitals acquires a 450-bed super-specialty hospital in Greater Bengaluru for ₹1,650 Cr, lifting its South cluster capacity to 3,850 beds.

Key Takeaways
- Apollo Hospitals Enterprise executed binding agreements to acquire an operating 450-bed super-specialty tertiary care hospital in Bengaluru for ₹1,650 crore.
- The acquisition valuation works out to ₹3.67 crore per operational bed, expanding Apollo's Karnataka cluster network to 1,800 beds.
- The acquired hospital generates ₹410 crore in annual operational revenue with an existing operating EBITDA margin of 23.2%.
Healthcare conglomerate Apollo Hospitals Enterprise Limited announced that it has signed a definitive business transfer agreement to acquire a 100% operational stake in a newly built 450-bed super-specialty tertiary hospital located along the Outer Ring Road corridor in Greater Bengaluru. The transaction, valued at an enterprise value of ₹1,650 crore, marks Apollo's largest single hospital asset acquisition in Southern India and reinforces its market leadership across Karnataka, taking its regional footprint to 1,800 operational beds across six tertiary institutions.
What Happened
The acquired multi-specialty healthcare facility is situated on a 4.2-acre freehold land parcel with a built-up area of 520,000 square feet. It features 12 advanced modular operation theaters, a 120-bed intensive care unit (ICU), dedicated robotic surgical suites, and comprehensive oncology radiation facilities including a TrueBeam linear accelerator. The hospital currently operates 310 commissioned beds with an average occupancy rate of 71%, with immediate infrastructure readiness to scale to full 450-bed capacity within six months.
The ₹1,650 crore transaction valuation reflects an enterprise metric of ₹3.67 crore per bed. The acquisition will be financed through a mix of internal cash accruals (₹750 crore) and long-term bank debt (₹900 crore) raised at an attractive interest rate of 8.10% per annum. The asset is projected to be immediately EBITDA-accretive, generating estimated annual operating revenue of ₹410 crore and EBITDA of ₹95 crore in its first full year of consolidated operations.
Apollo Hospitals Network & Healthcare Metric Snapshot
| Healthcare Operational Metric | Post-Acquisition FY27 | Pre-Acquisition FY26 | YoY Variance (%) |
|---|---|---|---|
| Total Operational Hospital Beds | 10,480 Beds | 9,820 Beds | +6.7% |
| Karnataka Regional Cluster Beds | 1,800 Beds | 1,350 Beds | +33.3% |
| Average Revenue per Occupied Bed (ARPOB) | ₹61,200 / day | ₹56,800 / day | +7.7% Pricing Power |
| Inpatient Occupancy Ratio (%) | 69.4% | 68.1% | +130 bps Utilization |
| Mature Hospital EBITDA Margin | 25.1% | 24.6% | +50 bps Expansion |
| Consolidated Net Debt-to-EBITDA | 1.18x | 0.98x | +20 bps Prudent Debt |
Sector Context & Earnings Quality
The Indian private healthcare sector has entered a structural growth phase characterized by rapid bed additions and regional consolidation. With rising penetration of retail health insurance, an aging demographic profile, and increasing prevalence of chronic lifestyle diseases (oncology, cardiology, neurology), tertiary hospitals in tech hubs like Bengaluru command industry-leading ARPOBs exceeding ₹60,000 per day.
For Apollo Hospitals, acquiring an operating asset along the Outer Ring Road circumvents the traditional four-to-five-year greenfield construction and regulatory licensing gestation period. By integrating the hospital into Apollo's central pharmacy procurement supply chain and clinical specialist network, management expects to expand the acquired facility's operating EBITDA margin from 23.2% to 26.5% within 18 months through administrative synergies and high-end oncology case mix expansion.
Independent TradeKaizen Analysis & Key Risks
TradeKaizen assesses this acquisition as an exceptional strategic expansion. Securing a prime healthcare campus in East Bengaluru's technology corridor positions Apollo to capture high-value corporate insurance and medical tourism flows. At ₹3.67 crore per bed, the transaction multiple is attractive compared to recent private equity hospital acquisitions in metro markets that traded between ₹4.2 and ₹5.0 crore per bed.
The primary operational risk is clinical talent retention. Retaining senior surgeons and department heads during the management integration phase is critical to maintaining inpatient volume momentum. Furthermore, any regulatory changes by state health authorities regarding pricing caps on medical implants or procedural packages could temporarily constrain gross operating margins.
Disclaimer: This analysis is published by TradeKaizen Financial Desk for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities.
Sources & References
- View sourceBSE IndiaExchange / Regulatory Filing
Apollo Hospitals Enterprise Limited Stock Exchange Filing - Hospital Acquisition Disclosure
- View sourceNational Stock ExchangePrimary Announcement
National Stock Exchange Press Release - Apollo Healthcare Network Expansion
TradeKaizen Financial Desk
Financial News Desk
TradeKaizen Financial Desk publishes source-attributed financial news and market analysis on TradeKaizen.
